BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8879702)

  • 21. [Chemotherapy of non-seminoma testicular cancer. Chances of recovery in a metastasizing malignant tumor].
    Gallmeier WM; Kaiser G; Bruntsch U
    MMW Munch Med Wochenschr; 1984 Jan; 126(2):14-9. PubMed ID: 6422260
    [No Abstract]   [Full Text] [Related]  

  • 22. Testicular relapse after chemotherapy for malignant teratoma.
    Chan S; Sikora K
    Br Med J (Clin Res Ed); 1987 Oct; 295(6606):1098-9. PubMed ID: 3120897
    [No Abstract]   [Full Text] [Related]  

  • 23. Progress in the management of testicular germ-cell tumours.
    Oliver RT
    Practitioner; 1982 Nov; 226(1373):1903-15. PubMed ID: 6891458
    [No Abstract]   [Full Text] [Related]  

  • 24. Safer cancer chemotherapy using a kinetically based experimental approach.
    Price LA; Hill BT
    Mt Sinai J Med; 1985 Jun; 52(6):452-9. PubMed ID: 3875025
    [No Abstract]   [Full Text] [Related]  

  • 25. Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
    de Bono JS; Paul J; Simpson A; Anthoney A; Kirk D; Underwood M; Graham J; Kaye SB
    Br J Cancer; 2000 Aug; 83(4):426-30. PubMed ID: 10945485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute leukemia following testicular carcinoma.
    Kerbrat P; Le Prise PY
    J Clin Oncol; 1985 Sep; 3(9):1287. PubMed ID: 3861776
    [No Abstract]   [Full Text] [Related]  

  • 27. Testicular germ cell tumor with rhabdomyosarcoma successfully treated by disease-adapted chemotherapy including high-dose chemotherapy: case report and review of the literature.
    Korfel A; Fischer L; Foss HD; Koch HC; Thiel E
    Bone Marrow Transplant; 2001 Oct; 28(8):787-9. PubMed ID: 11781632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
    Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cis-diamminated-dichloroplatinum (CDDP) in the chemotherapy of testicular dysembryomas and choriocarcinomas (author's transl)].
    Amiel JL; Droz JP; Tursz T; Ben Ayed F; Gastiaburu J; Rouesse J
    J Urol (Paris); 1980; 86(6):463-5. PubMed ID: 7192300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cytostatic treatment of non-seminoma testicular carcinomas].
    Brockmann B; Matthias M
    Z Arztl Fortbild (Jena); 1983; 77(20):863-6. PubMed ID: 6686394
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapy of testicular cancer: a surgeon's view.
    Dindyal S; Bhuva N; Sooriakumaran P
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):109-12. PubMed ID: 15757443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Randomized phase III study on nonseminomatous testicular tumor].
    Rexer H
    Urologe A; 2004 Nov; 43(11):1432-3. PubMed ID: 15526083
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
    Kawai K; Hinotsu S; Oikawa T; Sekido N; Hattori K; Miyanaga N; Hasegawa Y; Kojima H; Shimazui T; Akaza H
    Jpn J Clin Oncol; 2006 Nov; 36(11):723-30. PubMed ID: 17082218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose intensity: its limitation and the M. D. Anderson Cancer Center's view of its application.
    Amato RJ
    Semin Urol Oncol; 1998 May; 16(2):94-8. PubMed ID: 9649232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection.
    Svatek RS; Spiess PE; Sundi D; Tu SM; Tannir NM; Brown GA; Kamat AM; Wood CG; Pisters LL
    Cancer; 2009 Mar; 115(6):1310-7. PubMed ID: 19156903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy in patients with metastatic or relapsed germ-cell tumours.
    Rick O; Siegert W; Beyer J
    Cancer Treat Rev; 2001 Oct; 27(5):283-8. PubMed ID: 11871864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Significance pf retroperitoneal lymphadenectomy in the treatment of disseminated germinogenic testicular tumors after induction chemotherapy].
    Mitin AV; Figurin KM; Matveev BP; Tiuliandin SA; Bukharin BV; Volkova MI; Matveev VB
    Urologiia; 2000; (6):12-6. PubMed ID: 11186312
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemotherapy in patients with teratoma with malignant transformation.
    El Mesbahi O; Terrier-Lacombe MJ; Rebischung C; Theodore C; Vanel D; Fizazi K
    Eur Urol; 2007 May; 51(5):1306-11; discussion 1311-2. PubMed ID: 17081678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stage I testicular cancer management and necessity for surgical expertise.
    Sheinfeld J; Motzer RJ
    J Clin Oncol; 2008 Jun; 26(18):2934-6. PubMed ID: 18458042
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chemotherapy for metastatic germ cell tumours of the testis].
    Culine S
    Rev Prat; 2007 Feb; 57(4):385-8. PubMed ID: 17455740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.